Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction

Published:2016-07 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Chao,Ding Lei,Sun Chiao-Wang,Wu Li-Chen,Zhou Dewang,Pawlik Kevin M.,Khodadadi-Jamayran Alireza,Westin Erik,Goldman Frederick D.,Townes Tim M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep30422.pdf

Reference52 articles.

1. Ingram, V. M. A Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin. Nature 178, 792- 794 (1956).

2. Ingram, V. M. Gene Mutations in Human Hæmoglobin: the Chemical Difference Between Normal and Sickle Cell Hæmoglobin. Nature 180, 326- 328 (1957).

3. Thomas, E. D. & Blume, K. G. Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 5, 341–6 (1999).

4. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–76 (2006).

5. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797–801 (2009).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09

2. Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells;PLOS ONE;2023-11-29

3. CRISPR/Cas9-based gene-editing technology for sickle cell disease;Gene;2023-07

4. Cardiovascular consequences of sickle cell disease;Biophysics Reviews;2022-09

5. Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing;Neuro-Oncology Advances;2022-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3